Zentek Ltd. (CVE:ZEN - Get Free Report)'s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$1.67 and traded as low as C$1.46. Zentek shares last traded at C$1.46, with a volume of 41,455 shares.
Zentek Stock Up 1.4%
The stock's fifty day moving average is C$1.93 and its two-hundred day moving average is C$1.68. The company has a current ratio of 2.06, a quick ratio of 7.59 and a debt-to-equity ratio of 4.97. The firm has a market cap of C$151.01 million, a P/E ratio of -13.87 and a beta of 0.77.
Insider Activity at Zentek
In other news, Senior Officer Colin Stuart Van Der Kuur sold 15,000 shares of the stock in a transaction on Thursday, May 8th. The shares were sold at an average price of C$2.20, for a total value of C$33,000.00. 6.01% of the stock is owned by insiders.
Zentek Company Profile
(
Get Free Report)
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.
Featured Articles
Before you consider Zentek, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.
While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.